Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06001788
Title Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Hospital at Yale New Haven RECRUITING New Haven Connecticut 06511 United States Details
The University of Kansas RECRUITING Kansas City Kansas 66160 United States Details
Henry Ford Cancer Institute RECRUITING Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021 United States Details
Prisma Health RECRUITING Greenville South Carolina 29615 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field